Tuesday, March 15, 2016

Question of the Day March 15, 2016 What are the potential ways for the FDA or DOJ to get the "office use" issue before the judiciary? What are the pros vs. cons of this branch of government having the judiciary involved in this issue? Why haven't compounders made this challenge in court?


No comments: